SAN MATEO, Calif. – The U.S. Food and Drug Administration has granted clearance for over-the-counter sales of Adherium’s Hailie sensor for use with ProAir HFA, Ventolin HFA and Flovent HFA asthma inhalers. The Hailie sensor, previously known as Smartinhaler, is a device that attaches to a patient’s asthma or chronic obstructive pulmonary disease medication inhaler to monitor and promote adherence as part of a self-management plan. “This latest clearance kicks off our official entry into the U.S. consumer market, giving the tens of millions of U.S. patients suffering from chronic respiratory conditions their own sidekick for asthma and COPD,” said Arik Anderson, CEO of Adherium, in a statement. The company’s Hailie solution tracks medication use and reminds the user with helpful nudges when it’s time to take doses. It also provides access to usage history to better understand patterns in the patient’s asthma and COPD. Adherium is also launching an online portal for health care professionals and clinicians that uses Bluetooth technology to provide patient-group data collection and reporting from Hailie sensors.
You are here: / / FDA grants clearance to Hailie inhaler sensor